Testing effectiveness (Phase 2)Not Yet RecruitingNCT07823322
What this trial is testing
Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
Who this might be right for
CRC (Colorectal Cancer)
Incyte Corporation 40